等待開盤 05-22 09:30:00 美东时间
0.000
0.00%
Grove Collaborative Hldgs (NYSE:GROV) raises FY2026 sales outlook from $140.000 million-$150.000 million to $142.500 million-$152.500 million vs $145.674 million estimate.
05-08 04:44
Grove Collaborative Hldgs (NYSE:GROV) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 70 percent increase over losses of $(0.10) per share from
05-08 04:43
Grove Collaborative Hldgs (NYSE:GROV) sees FY2026 sales of $140.000 million-$150.000 million vs $177.914 million analyst estimate.
03-06 05:12
The Q4 earnings report for Grove Collaborative Hldgs (NYSE:GROV) was released o...
03-06 05:12
Grove Collaborative Hldgs (NYSE:GROV) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 76.19 percent increase over losses of $(0.21) per
03-06 05:11
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
Grove Collaborative Hldgs (NYSE:GROV) is gearing up to announce its quarterly e...
03-05 03:02
Grove Collaborative Hldgs (NYSE:GROV) sees FY2025 sales of $172.500 million-$175.000 million vs $181.900 million analyst estimate.
2025-11-14 05:13
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43